{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:15:52Z","timestamp":1788300952603,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["116060"],"award-info":[{"award-number":["116060"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008445","name":"Parkinsonforeningen","doi-asserted-by":"publisher","award":["A858"],"award-info":[{"award-number":["A858"]}],"id":[{"id":"10.13039\/100008445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007352","name":"Staatssekretariat f\u00fcr Bildung, Forschung und Innovation","doi-asserted-by":"publisher","award":["17.00038"],"award-info":[{"award-number":["17.00038"]}],"id":[{"id":"10.13039\/501100007352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010809","name":"Jascha Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025194","name":"Roskilde Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.nbd.2026.107575","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T06:52:29Z","timestamp":1786690349000},"page":"107575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multiple system atrophy-derived \u03b1-synuclein fibrils are more potent and display oligodendrocyte cell tropism compared to Parkinson's disease-derived fibrils"],"prefix":"10.1016","volume":"228","author":[{"given":"Anne-Line Strange","family":"Laursen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Will\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Fenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Volbracht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise Torp","family":"Dalgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Melki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Fog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Sotty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2026.107575_bb0005","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00401-019-02010-2","article-title":"Selective vulnerability in \u03b1-synucleinopathies","volume":"138","author":"Alegre-Abarrategui","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2026.107575_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76565-6","article-title":"The secondary structural difference between Lewy body and glial cytoplasmic inclusion in autopsy brain with synchrotron FTIR micro-spectroscopy","volume":"10","author":"Araki","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2026.107575_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2026.107575_bb0020","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-009-0538-8","article-title":"Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction","volume":"117","author":"Beach","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2026.107575_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3575","article-title":"Structural and functional characterization of two alpha-synuclein strains","volume":"4","author":"Bousset","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2026.107575_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2026.107575_bb0035","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1788-16.2017","article-title":"Prying into the prion hypothesis for Parkinson\u2019s disease","volume":"37","author":"Brundin","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107575_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-025-09698-1","article-title":"Synthetic \u03b1-synuclein fibrils replicate in mice causing MSA-like pathology","author":"Burger","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107575_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awv114","article-title":"Expanding the spectrum of neuronal pathology in multiple system atrophy","volume":"138","author":"Cykowski","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107575_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc4364","article-title":"Novel self-replicating \u03b1-synuclein polymorphs that escape ThT monitoring can spontaneously emerge and acutely spread in neurons","volume":"6","author":"De Giorgi","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.nbd.2026.107575_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-019-0164-x","article-title":"Efficient RT-QuIC seeding activity for \u03b1-synuclein in olfactory mucosa samples of patients with Parkinson\u2019s disease and multiple system atrophy","volume":"8","author":"De Luca","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.nbd.2026.107575_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020269","article-title":"Oligodendrocytes prune axons containing \u03b1-synuclein aggregates in vivo: Lewy neurites as precursors of glial cytoplasmic inclusions in multiple system atrophy?","volume":"13","author":"De Nuccio","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.nbd.2026.107575_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032477","article-title":"The interplay between \u03b1-synuclein and microglia in \u03b1-Synucleinopathies","volume":"24","author":"Deyell","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2026.107575_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090659","article-title":"Unlike twins: an NMR comparison of two \u03b1-synuclein polymorphs featuring different toxicity","volume":"9","author":"Gath","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2026.107575_bb0075","doi-asserted-by":"crossref","DOI":"10.1007\/s12104-013-9526-y","article-title":"Yet another polymorph of \u03b1-synuclein: solid-state sequential assignments","volume":"8","author":"Gath","year":"2014","journal-title":"Biomol. NMR Assign."},{"key":"10.1016\/j.nbd.2026.107575_bb0080","doi-asserted-by":"crossref","DOI":"10.1212\/01.WNL.0000078192.95645.E6","article-title":"[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy","volume":"61","author":"Gerhard","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107575_bb0085","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2026.107575_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/cells13030253","article-title":"Characterization of pSer129-\u03b1Syn pathology and neurofilament light-chain release across in vivo, ex vivo, and in vitro models of pre-formed-fibril-induced \u03b1Syn aggregation","volume":"13","author":"Hansen","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.nbd.2026.107575_bb0095","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2026.107575_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-024-01104-7","article-title":"A novel mouse model for investigating \u03b1-synuclein aggregates in oligodendrocytes: implications for the glial cytoplasmic inclusions in multiple system atrophy","volume":"17","author":"Ishimoto","year":"2024","journal-title":"Mol. Brain"},{"key":"10.1016\/j.nbd.2026.107575_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/mds.28814","article-title":"Glia imaging differentiates multiple system atrophy from Parkinson\u2019s disease: a positron emission tomography study with [11C]PBR28 and machine learning analysis","volume":"37","author":"Jucaite","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2026.107575_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00198","article-title":"Overview of general and discriminating markers of differential microglia phenotypes","volume":"14","author":"Jurga","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2026.107575_bb0115","doi-asserted-by":"crossref","DOI":"10.1093\/jnen\/nly035","article-title":"Immunohistochemical and molecular investigations show alteration in the inflammatory profile of multiple system atrophy brain","volume":"77","author":"Kiely","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2026.107575_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00501-z","article-title":"Neuropathology and molecular diagnosis of Synucleinopathies","volume":"16","author":"Koga","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2026.107575_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/mds.22369","article-title":"Transplanted dopaminergic neurons develop PD pathologic changes: a second case report","volume":"23","author":"Kordower","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2026.107575_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/mds.27620","article-title":"Widespread microglial activation in multiple system atrophy","volume":"34","author":"K\u00fcbler","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2026.107575_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-021-00264-w","article-title":"Similar neuronal imprint and no cross-seeded fibrils in \u03b1-synuclein aggregates from MSA and Parkinson\u2019s disease","volume":"8","author":"Laferri\u00e8re","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.nbd.2026.107575_bb0140","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-026-02346-3","article-title":"\u03b1-Synuclein overexpression increases the tropism of pre-formed fibrils and MSA-patient derived seeds towards oligodendroglia","author":"Laursen","year":"2026","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2026.107575_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2020.11.011","article-title":"Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging","volume":"82","author":"Lavisse","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2026.107575_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2026.107575_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02574-z","article-title":"Brain microglia activation and peripheral adaptive immunity in Parkinson\u2019s disease: a multimodal PET study","volume":"19","author":"Liu","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2026.107575_bb0160","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-022-02425-4","article-title":"Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human \u03b1-synuclein transgenic mice","volume":"143","author":"Lloyd","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2026.107575_bb0165","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/2211-5463.13110","article-title":"Seeded assembly in vitro does not replicate the structures of \u03b1-synuclein filaments from multiple system atrophy","volume":"11","author":"L\u00f6vestam","year":"2021","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.nbd.2026.107575_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2016.08.053","article-title":"Molecular and biological compatibility with host alpha-synuclein influences fibril pathogenicity","volume":"16","author":"Luk","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2026.107575_bb0175","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awt037","article-title":"Prion-like spreading of pathological \u03b1-synuclein in brain","volume":"136","author":"Masuda-Suzukake","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107575_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.742065","article-title":"Microglia in neuroinflammation and neurodegeneration: from understanding to therapy","volume":"15","author":"Muzio","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2026.107575_bb0185","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-023-01365-5","article-title":"\u237a-synuclein structural diversity and the cellular environment in \u237a-synuclein transmission models and humans","volume":"20","author":"Peelaerts","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2026.107575_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/nature14547","article-title":"\u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"522","author":"Peelaerts","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107575_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-018-0104-4","article-title":"Cellular milieu imparts distinct pathological \u03b1-synuclein strains in \u03b1-synucleinopathies","volume":"557","author":"Peng","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107575_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-022-00382-6","article-title":"Multiple system atrophy","volume":"8","author":"Poewe","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.nbd.2026.107575_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2026.107575_bb0210","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1514475112","article-title":"Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism","volume":"112","author":"Prusiner","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2026.107575_bb0215","article-title":"Neocortical neuronal loss in patients with multiple system atrophy: a stereological study","volume":"27","author":"Salvesen","year":"2017","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.nbd.2026.107575_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.str.2026.04.014","article-title":"The amyloid packing difference: a pairwise comparison metric for amyloid structures","volume":"34","author":"Scheres","year":"2026","journal-title":"Structure"},{"key":"10.1016\/j.nbd.2026.107575_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2317-6","article-title":"Structures of \u03b1-synuclein filaments from multiple system atrophy","volume":"585","author":"Schweighauser","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107575_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/s44320-026-00199-5","article-title":"Structure-function relationship of alpha-synuclein fibrillar polymorphs derived from distinct synucleinopathies","volume":"22","author":"Serdiuk","year":"2026","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.nbd.2026.107575_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107575_bb0240","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.neuron.2026.01.014","article-title":"Stochastic misfolding drives the emergence of distinct \u03b1-synuclein strains","volume":"114","author":"So","year":"2026","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2026.107575_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23682-z","article-title":"Phenotypic manifestation of \u03b1-synuclein strains derived from Parkinson\u2019s disease and multiple system atrophy in human dopaminergic neurons","volume":"12","author":"Tanudjojo","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2026.107575_bb0250","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awac061","article-title":"Host oligodendrogliopathy and \u03b1-synuclein strains dictate disease severity in multiple system atrophy","volume":"146","author":"Torre-Muruzabal","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107575_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.neures.2025.04.008","article-title":"Fibril-seeded animal models of synucleinopathies: pathological mechanisms, disease modeling, and therapeutic implications","volume":"216","author":"Uemura","year":"2025","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.nbd.2026.107575_bb0260","doi-asserted-by":"crossref","DOI":"10.1093\/jnen\/nlz070","article-title":"Slow progressive accumulation of oligodendroglial alpha-synuclein (a-syn) pathology in synthetic a-syn fibril-induced mouse models of synucleinopathy","volume":"78","author":"Uemura","year":"2019","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2026.107575_bb0265","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00401-020-02157-3","article-title":"The structural differences between patient-derived \u03b1-synuclein strains dictate characteristics of Parkinson\u2019s disease, multiple system atrophy and dementia with Lewy bodies","volume":"139","author":"Van der Perren","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2026.107575_bb0270","doi-asserted-by":"crossref","DOI":"10.1007\/s12104-015-9628-9","article-title":"Further exploration of the conformational space of \u03b1-synuclein fibrils: solid-state NMR assignment of a high-pH polymorph","volume":"10","author":"Verasdonck","year":"2016","journal-title":"Biomol. NMR Assign."},{"key":"10.1016\/j.nbd.2026.107575_bb0275","article-title":"Seed amplification of MSA alpha-synuclein aggregates preserves the biological and structural properties of brain-derived aggregates","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2026.107575_bb0280","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.cell.2020.04.007","article-title":"The Allen mouse brain common coordinate framework: a 3D reference atlas","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2026.107575_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/mds.29005","article-title":"The Movement Disorder Society criteria for the diagnosis of multiple system atrophy","volume":"37","author":"Wenning","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2026.107575_bb0290","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-025-00469-6","article-title":"Refining \u03b1-synuclein seed amplification assays to distinguish Parkinson\u2019s disease from multiple system atrophy","volume":"14","author":"Wiseman","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.nbd.2026.107575_bb0295","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-019-01959-4","article-title":"Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines","volume":"137","author":"Woerman","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2026.107575_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713199","article-title":"Beyond strains: molecular diversity in alpha-synuclein at the Center of Disease Heterogeneity","volume":"24","author":"Wojewska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2026.107575_bb0305","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA118.004471","article-title":"Parkinson\u2019s disease and multiple system atrophy have distinct -synuclein seed characteristics","volume":"294","author":"Yamasaki","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2026.107575_bb0310","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-022-05319-3","article-title":"Structures of \u03b1-synuclein filaments from human brains with Lewy pathology","volume":"610","author":"Yang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107575_bb0315","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13196","article-title":"Alpha-synuclein fibrils amplified from multiple system atrophy and Parkinson\u2019s disease patient brain spread after intracerebral injection into mouse brain","volume":"33","author":"Zhang","year":"2023","journal-title":"Brain Pathol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126003207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126003207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:54:57Z","timestamp":1788299697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126003207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":63,"alternative-id":["S0969996126003207"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107575","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple system atrophy-derived \u03b1-synuclein fibrils are more potent and display oligodendrocyte cell tropism compared to Parkinson's disease-derived fibrils","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107575"}}